NCI maintains paylines for early-stage investigators, cuts funding for other R01s and noncompeting grants in FY24 April 05, 2024Vol.50 No.14By Matthew Bin Han Ong
White House White House misses deadline to finalize FDA rule banning menthol cigarettes, prompting lawsuit from health groups April 05, 2024Vol.50 No.14By Jacquelyn Cobb
Trials & Tribulations A new standard in cancer care: Integrated screening, stepped collaborative care for common and distressing symptoms April 05, 2024Vol.50 No.14By Jennifer A. Steel
FreeIn the Archives ACS celebrates Black leaders whose contributions shaped health equity in cancer April 05, 2024Vol.50 No.14
Conversation with The Cancer Letter Rathmell: A tough budget is an opportunity to make sure NCI is “doing what is best for the American public” March 29, 2024Vol.50 No.13By Paul Goldberg
Capitol Hill With reduced FY24 funding, NCI prepares to make cuts March 29, 2024Vol.50 No.13By Matthew Bin Han Ong
Regulatory News Exercising new powers, FDA issues Complete Response Letters based on insufficient enrollment in confirmatory trials March 29, 2024Vol.50 No.13By Paul Goldberg
Daniel Snyder, former Washington Commanders owner, donates riverfront “château” to ACS March 29, 2024Vol.50 No.13By Jacquelyn Cobb
FreeIn the Archives Women’s History Month—How “Dr. Susan Love’s Breast Book” has remained the “bible” for women with breast cancer since 1990 March 29, 2024Vol.50 No.13By Alexandria Carolan
